Drug Shortage Report for TARO-CARBAMAZEPINE CHEWABLE TABLETS
Report ID | 107007 |
Drug Identification Number | 02244403 |
Brand name | TARO-CARBAMAZEPINE CHEWABLE TABLETS 100MG |
Common or Proper name | CARBAMAZEPINE CHEWABLE TABLETS 100MG |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | CARBAMAZEPINE |
Strength(s) | 100MG |
Dosage form(s) | TABLET (CHEWABLE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N03AF |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-21 |
Estimated end date | 2020-02-28 |
Actual end date | 2020-03-06 |
Shortage status | Resolved |
Updated date | 2020-03-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-03-07 | French | Compare |
v3 | 2020-03-07 | English | Compare |
v2 | 2020-02-24 | French | Compare |
v1 | 2020-02-24 | English | Compare |
Showing 1 to 4 of 4